News
Filter by:
Newsletter: Connecting Capabilities: retrospective on the impact and learnings from cross institutional collaboration
MedTech SuperConnector Newsletter June 2020 We are excited to be…
Collaborating & Networking on Cohort Three
The Imperial-led medical technology entrepreneurship programme MedTech SuperConnector (MTSC) has…
On target: A clever catheter to track and treat brain diseases
Cohort Three participant Riccardo Secoli recent feature by Imperial College…
Newsletter: Accepting applications for Cohort Four in partnership with GSK NEXT & Beyond teams
MedTech SuperConnector Newsletter March 2020 We’re pleased to announce that…
Future of Pain, applications for Cohort Four in partnership with GSK Consumer Healthcare NEXT & Beyond
We have partnered with GSK Consumer Healthcare Next & Beyond…
Collaborating to collaborate
Research England has released its first report highlighting the learnings and successes of the Connecting Capability Fund (CCF) projects.
Newsletter: A lung therapy trumpet and other medtech innovations
MedTech SuperConnector Newsletter December 2019 Here at MedTech SuperConnector we’re…
Out of the lab: welcoming Cohort Three
The Medtech SuperConnector (MTSC) Venture Accelerator programme announces a new…
Innovations looking to change the future of mental healthcare
The second cohort of ventures from the MedTech SuperConnector presented…
MedTech SuperConnector Cohort Two Showcase
You’re invited to the MedTech SuperConnector Cohort Two Showcase. Meet…
Newsletter: Knowledge Exchange is the Driver of Innovation
MedTech SuperConnector Newsletter September 2019 Welcome back! We’ve had a…
Become a member
Join our mailing list to receive updates about Medtech SuperConnector.
You can unsubscribe by clicking the link in our emails where indicated, or emailing mtsc@imperial.ac.uk. Or you can update your contact preferences. We promise to keep your details safe and secure. We won’t share your details outside of Medtech Superconector without your permission. Find out more about how we use personal information in our Privacy Policy.